Skip to main content

Trana Discovery, Bayer Sign Fungicide Collaboration

Global agricultural giant Bayer and Cary's Trana Discovery have signed a collaboration agreement to explore ways to use Trana’s disease-fighting technology in plant-protection products.

Pining for Truffles, Mycorrhiza Biotech Achieves First Harvest

When Nancy Rosborough read an article in the Washington Post about growing truffles, a gourmet delicacy that’s normally harvested from the wild, the novel idea took root as a Burlington biotech company.

NCBiotech Awards $1.4 Million in Latest Quarter

The North Carolina Biotechnology Center awarded 13 grants and loans totaling $1.4 million to universities and bioscience companies in the second quarter of its 2016-2017 fiscal year ending Dec. 31.

Locus Biosciences Lifts Lid on Crafty CRISPR to Bust Bad Bacteria

Raleigh bioscience startup Locus Biosciences, a spinout of North Carolina State University, is using a version of the hot gene-editing technology called CRISPR to cut a new path to the discovery and development of novel antibiotics.

Inside View: A Kind Gentleman and Nobel Laureate

It was a gray afternoon in March, 2008 at the North Carolina Biotechnology Center. A kindly looking gentleman stood in our Congressional Room, surrounded by a group of North Carolina’s brightest young scientists, winners of various science competitions across the state that year.

Two FDA Chiefs, Other Luminaries to Address CED Life Science Conference

Two former commissioners of the U.S. Food and Drug Administration, both with ties to Duke University, are among the speakers headlining the Council for Entrepreneurial Development’s 26th annual Life Science Conference in Raleigh Feb. 28 and March 1.

UNC Nobel Laureate Oliver Smithies Dead at 91

Oliver Smithies, D.Phil., who was recruited to North Carolina with grant funding from the North Carolina Biotechnology Center and won the Nobel Prize in Physiology or Medicine 20 years later, died today at the age of 91.

New G1 Trials Target Breast Cancer

G1 Therapeutics, a clinical-stage oncology company based in Research Triangle Park, is expanding its search for new anti-cancer weapons by launching three more clinical trials targeting breast cancer.

Humacyte Starts Phase 2 Trial of Bioengineered Blood Vessel

Humacyte, a regenerative medicine company based in Morrisville, has launched a Phase 2 clinical trial of Humacyl, its bioengineered blood vessel, in patients with peripheral arterial disease.

White Labs Set to Begin Asheville Yeast Production

Two years after announcing plans for a yeast production facility in Asheville, West Coast fermentation specialty company White Labs is about to start “Yeast Coast” production at its new factory in January 2017.


Subscribe to RSS - NCBiotech